(Q73078899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sebastien Jeay

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Pichard C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Bernichtein S

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Touraine P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Kelly PA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Goffin V

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

4695-4705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11032019%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203846

1 November 2019

exact match

0 references

cites work

Prolactin-induced protein kinase C activity in a mouse mammary cell line (NOG-8)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin as an autocrine/paracrine factor in breast tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Signal transduction in mammary tumorigenesis: a transgenic perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin as a mitogen in mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Mammary gland oncogenes as indicators of pathways important in mammary gland development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Growth factor synthesis and human breast cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Rational design of potent antagonists to the human growth hormone receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

The human growth hormone antagonist B2036 does not interact with the prolactin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

The prolactin/growth hormone receptor family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin stimulates serine/tyrosine phosphorylation and formation of heterocomplexes of multiple Stat5 isoforms in Nb2 lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Involvement of prolactin in breast cancer: redefining the molecular targets.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin as a Chemoattractant for Human Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Morphologic criteria and detection of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Stat3 activation by Src induces specific gene regulation and is required for cell transformation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Prolactin: the forgotten hormone of human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Role of protein kinase C in the prolactin-induced responses in mouse mammary gland explants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

The role of prolactin and growth hormone in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021

Cancer incidence and mortality, 1973-1995: a report card for the U.S.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203846

7 January 2021